English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Correction to: British Journal of Cancer (2003) 88, 613–623; doi:10.1038/sj.bjc.66000681 Reference on p. 614 and in Table 2 (p. 615) to human recombinant arginine decarboxylase is incorrect, as elsewhere in the article. The enzyme was prepared by the overexpression of biosynthetic arginine decarboxylase (speA), originating in Escherichia coli and purified from E.

Erratum: Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures